Results 141 to 150 of about 972,681 (362)
MULTIPLE BONE METASTASIS OF BENIGN MENINGIOMA: A CASE REPORT
Reports of metastatic meningiomas are rare. The previous existence of a cranial neoplasm, the non-contiguous site of metastasis and the close histological resemblance point towards the metastatic nature of extracranial ...
Yu. M. Bogdaev+5 more
doaj +1 more source
Splenic metastasis from gastrointestinal neoplasms: a review.
Spleen metastases from solid tumours are rather exceptional, especially for those located in the digestive tract. Although these lesions are usually associated with multivisceral disease at terminal stage, several cases of isolated lesions have also been described in the literature.
Delaunoit, T+3 more
openaire +2 more sources
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen+12 more
wiley +1 more source
Urothelial carcinoma of the bladder with abnormal inguinal metastasis: A case report
Bladder cancer metastasis to the inguinal lymph nodes is a rare event. We report a case of a 73 years old male patient, known case of hypertension, diabetes, and bladder cancer. He was admitted to King Faisal Specialist Hospital (KFSHRC) in Riyadh, Saudi
Rahaf K. Bashaweeh+5 more
doaj
Unexpected Metastasis of Intraductal Papillary Mucinous Neoplasm of the Bile Duct into Thoracic Cavity with Direct Extension: Case Report [PDF]
Eung Tae Kim+4 more
openalex +1 more source
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma+9 more
wiley +1 more source
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci+6 more
wiley +1 more source
Landscape of BRAF transcript variants in human cancer
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda+5 more
wiley +1 more source
Agreement Between Cytology and Histopathology for Regional Lymph Node Metastasis in Dogs With Melanocytic Neoplasms [PDF]
Janet A. Grimes+6 more
openalex +1 more source